Mesoblast (MEOBF) Shares Outstanding (Entity) (2014 - 2026)
Powered by 
Analysis
Mesoblast (MEOBF) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 29.60 Mn |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 96.66 Mn |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 452.97 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | 69.33 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | 103.26 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 358.01 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 105.62 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 51.17 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 129.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.49 Mn |
| Jun 30, 2025 | 128.00 Mn |
| Jun 30, 2024 | 114.18 Mn |
| Jun 30, 2023 | 81.42 Mn |
| Jun 30, 2022 | 65.05 Mn |
| Jun 30, 2021 | 64.87 Mn |
| Jun 30, 2020 | 58.39 Mn |
| Jun 30, 2019 | 49.86 Mn |
| Jun 30, 2018 | 48.26 Mn |
| Jun 30, 2017 | 42.82 Mn |
| Jun 30, 2016 | 38.14 Mn |
| Jun 30, 2015 | 33.70 Mn |
| Jun 30, 2014 | 32.16 Mn |